US equities
|
NVDA
$239.81
▲+0.38%
SPCX
$173.11
▲+1.18%
MU
$1,064.38
▲+0.04%
MRVL
$284.99
▲+5.07%
AMD
$654.91
▲+3.67%
INTC
$114.00
▼-1.89%
SNDK
$1,672.03
▼-1.89%
AVGO
$378.65
▲+4.45%
NVDA
$239.81
▲+0.38%
SPCX
$173.11
▲+1.18%
MU
$1,064.38
▲+0.04%
MRVL
$284.99
▲+5.07%
AMD
$654.91
▲+3.67%
INTC
$114.00
▼-1.89%
SNDK
$1,672.03
▼-1.89%
AVGO
$378.65
▲+4.45%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about TRPM8
Recent news which mentions TRPM8
IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
June 25, 2024
Tags
Medical
United States
Cranbury
From
PRLog
Expert Opinions on Dry Eye Treatment Innovations
July 13, 2023
Tags
TRPM8
New Jersey
Clinical Trial
From
PRLog